Go Pro

F/m Emerald Life Sciences Innovation ETF (LFSC) Holdings List

$47.09 +0.27 (+0.58%)
As of 02:43 PM Eastern

What stocks does LFSC hold?

The F/m Emerald Life Sciences Innovation ETF (LFSC) top stock holdings include Travere Therapeutics, Cogent Biosciences, and Spyre Therapeutics. The top 25 LFSC holdings ordered by weight make up 91.47% of the total fund. LFSC is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete LFSC stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 LFSC Holdings

RankCompanyCurrent PriceWeightShares Held
1
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$61.94
+0.8%
7.86%175,197
2
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$37.63
+0.9%
7.52%232,085
3
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$103.28
+1.4%
7.48%93,991
4
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
$114.22
+3.4%
6.89%74,355
5
LivaNova PLC stock logo
LIVN
LivaNova
$82.25
+0.1%
6.60%103,869
6
Guardant Health, Inc. stock logo
GH
Guardant Health
$156.62
-1.8%
5.48%45,867
7
Billiontoone, Inc. stock logo
BLLN
Billiontoone
$93.00
-1.1%
4.84%44,245
8
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$74.03
+0.8%
3.89%61,793
9
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
$100.69
+1.9%
3.72%42,214
10
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
$214.91
+0.6%
3.54%19,258
11
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$499.45
-0.4%
3.31%8,044
12
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$114.52
+4.5%
3.16%35,798
13
Veradermics, Incorporated stock logo
MANE
Veradermics
$112.70
+1.5%
2.99%36,499
14
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$73.45
-3.3%
2.92%52,209
15
Savara Inc. stock logo
SVRA
Savara
$5.34
+1.2%
2.90%668,136
16
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
$18.42
+1.5%
2.81%195,241
17
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$88.36
-1.4%
2.56%42,991
18
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$183.21
+0.1%
2.20%16,651
19
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$22.03
+0.2%
2.13%136,761
20
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
$155.00
-1.0%
2.08%17,702
21
Corvus Pharmaceuticals, Inc. stock logo
CRVS
Corvus Pharmaceuticals
$14.73
-2.7%
1.75%169,648
22
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$118.89
-5.1%
1.31%18,316
23
CeriBell, Inc. stock logo
CBLL
CeriBell
$23.33
+0.3%
1.25%90,673
24
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$79.65
-1.9%
1.22%19,017
25
Hinge Health Inc. stock logo
HNGE
Hinge Health
$88.29
+1.0%
1.06%18,049

LFSC Geographic Exposure

LFSC's largest geographic exposure is United States at 92.1%, followed by United Kingdom at 6.7%.

  • United States
    92.1%
  • United Kingdom
    6.7%
  • Canada
    0.6%

LFSC Currency Exposure

LFSC is exclusively exposed to USD.

  • USD
    69.8%

LFSC Sector Exposure

LFSC's largest sector exposure is Health Care at 80.5%, followed by Consumer Discretionary at 5.7%.

  • Health Care
    80.5%
  • Consumer Discretionary
    5.7%

LFSC Industry Exposure

LFSC's largest industry exposure is Biotechnology at 58.8%, followed by Health Care Equipment & Supplies at 15.4%.

  • Biotechnology
    58.8%
  • Health Care Equipment & Supplies
    15.4%
  • Diversified Consumer Services
    5.7%
  • Pharmaceuticals
    2.8%
  • Health Care Providers & Services
    2.5%
  • Health Care Technology
    1.1%

LFSC Sub-Industry Exposure

LFSC's largest sub-industry exposure is Biotechnology at 55.6%, followed by Health Care Equipment at 15.4%.

  • Biotechnology
    55.6%
  • Health Care Equipment
    15.4%
  • Pharmaceuticals
    6.0%
  • Health Care Services
    2.5%
  • Health Care Technology
    1.1%

Related Companies and Tools


This page (NASDAQ:LFSC) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners